ArticlemBio2025
KSHV and HPV modulate epithelial-to-mesenchymal transition in oral epithelial cells.
Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Establishment and characterization of a new immortalized human adenomyosis epithelial-like cell line, tAEC21†.Biology of reproduction · 2026Article
- Effects of Eribulin on Epithelial-Mesenchymal Plasticity in Patient-Derived Breast Cancer Cultures and Excised Tissues.Cancers · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Most oral viral infections that manifest as oral diseases or cancers are caused by oncogenic human papillomavirus and herpesviruses. However, the mechanisms involved in the association between oral cancer and oncogenic virus infection are not well understood. In this study, we used telomerase (hTERT) -immortalized normal oral gingival keratinocytes (NOKs) and generated latent Kaposi's sarcoma-associated herpesvirus (KSHV)- and human papillomavirus 31 (HPV31)-infected NOKs. NOKs either stably maintaining HPV episomes or latently infected with KSHV acquired a fibroblast-like morphology and upregulated cell proliferation in both complete media and serum starvation culture conditions. Moreover, migration and invasion assays revealed that the KSHV- and HPV-infected NOKs show markedly higher migration and invasion activity compared to uninfected cells. We demonstrated that KSHV-NOK and HPV-NOK express much lower protein levels of the epithelial cell marker E-cadherin and significantly higher protein levels of mesenchymal cell marker vimentin, indicating that KSHV and HPV31 infection induces an epithelial-to-mesenchymal transition (EMT). Notably, after efficient vimentin knockdown using two different lentiviral short hairpin RNAs (shRNAs) or eribulin treatment, E-cadherin expression was restored, and phenotypic alterations (proliferation, migration, and invasion) caused by KSHV and HPV31 infection were abolished, suggesting that KSHV- and HPV31-induced EMTs play an important role in these phenotypic alterations by KSHV and HPV31. Given that changes in EMT are often associated with cancer progression, our results offer important insight into the mechanism behind KSHV and HPV infection and cancer, suggesting that EMT is a potential therapeutic target for KSHV- and HPV-driven cancers.IMPORTANCEThe oral cavity is believed to be a primary site where many viruses infect the human body. Kaposi's sarcoma-associated herpesvirus (KSHV) and human papillomavirus (HPV) are both found and cause cancers in the oral cavity. However, knowledge of how KSHV and HPV infection is connected to oral cancer (e.g., oncogenesis and metastasis) remains limited. Here, our study reveals that KSHV and high-risk HPV31 can induce epithelial-to-mesenchymal transition by upregulation of vimentin and downregulation of E-cadherin, which is vital for KSHV-normal oral gingival keratinocyte (NOK) and HPV-NOK to acquire cancer cell characteristics such as cell survival, migration, and invasion activities. For the first time, we show that knockdown of vimentin and eribulin treatment can restore E-cadherin and reverse epithelial-to-mesenchymal transition in KSHV- and HPV31-infected oral epithelial cells. These findings fill a gap in our understanding of oncogenesis and metastasis of oral cancers caused by KSHV and HPV31, revealing that vimentin may serve as a potential therapeutic molecular target for KSHV- and HPV-associated oral cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.